Clincosm LogoSign in Get a demo

Breast Cancer

Showing NaN - NaN of 177
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Baltimore, Dallas (Dose Fractionation)

Active, not recruiting
  • Breast Cancer
  • Dose Fractionation
  • Baltimore, Maryland
  • +1 more
Sep 7, 2022

Breast Cancer, Cancer of the Breast Trial in Saint Louis (drug, device, procedure)

Recruiting
  • Breast Cancer
  • Cancer of the Breast
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 29, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Breast Cancer Trial in United States (Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test)

Recruiting
  • Breast Cancer
  • Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test
  • Daphne, Alabama
  • +104 more
Aug 17, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +3 more
  • Chandler, Arizona
  • +226 more
Aug 11, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

Active, not recruiting
  • Breast Neoplasms
  • +7 more
  • Goodyear, Arizona
  • +38 more
Jun 29, 2022

Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)

Active, not recruiting
  • Breast Cancer
  • therapeutic conventional surgery
  • whole breast irradiation
  • Hot Springs, Arkansas
  • +349 more
Jun 16, 2022

Breast Cancer Trial in Georgia, United States (entinostat, atezolizumab, Placebo)

Completed
  • Breast Cancer
  • Birmingham, Alabama
  • +28 more
May 9, 2022

Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Amcenestrant-matching placebo
  • +5 more
  • Daphne, Alabama
  • +299 more
May 5, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

Active, not recruiting
Has Results
  • Breast Cancer
  • Trastuzumab deruxtecan (T-DXd)
  • Ado-trastuzumab emtansine (T-DM1)
  • Los Angeles, California
  • +163 more
Apr 1, 2022

Breast Cancer Trial in Dallas (Imagio OA/US)

Recruiting
  • Breast Cancer
  • Imagio OA/US
  • Dallas, Texas
    UT Southwestern
Apr 19, 2022

Breast Cancer Trial in Ireland, United States (bevacizumab, docetaxel, doxorubicin)

Completed
  • Breast Cancer
  • Bessemer, Alabama
  • +532 more
Apr 13, 2022

Breast Cancer, High Risk of Breast Cancer Trial in Dallas (da Vinci SP Surgical System)

Recruiting
  • Breast Cancer
  • High Risk of Breast Cancer
  • da Vinci SP Surgical System
  • Dallas, Texas
    UT Southwestern
Mar 21, 2022

Ovarian Cancer, Breast Cancer Trial in Dallas (Lynparza)

Active, not recruiting
  • Ovarian Cancer
  • Breast Cancer
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Mar 22, 2022

Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)

Terminated
Has Results
  • Triple-Negative Breast Neoplasms
  • +3 more
  • Tucson, Arizona
  • +53 more
Feb 24, 2022

Breast Cancer Trial in United States (Neratinib, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Indianapolis, Indiana
  • +5 more
Mar 2, 2022

Neutropenia, Breast Cancer Trial in Canada, Korea, Republic of, United States (SPI-2012, Pegfilgrastim, Docetaxel)

Completed
Has Results
  • Neutropenia
  • Breast Cancer
  • Glendale, Arizona
  • +80 more
Feb 28, 2022

Breast Cancer Trial in Worldwide (LEE011, Letrozole, BYL719)

Active, not recruiting
  • Breast Cancer
  • San Diego, California
  • +23 more
Feb 17, 2022

Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • TALZENNA capsule
  • Talazoparib soft gel capsule
  • Encinitas, California
  • +31 more
Feb 14, 2022

Breast Cancer, Head and Neck Squamous Cell Carcinoma, Colorectal Cancer Trial in Philadelphia, Dallas, Houston (ONM-100)

Completed
  • Breast Cancer
  • +6 more
  • Philadelphia, Pennsylvania
  • +2 more
Feb 9, 2022

Breast Cancer, Prostate Cancer, Ovarian Cancer Trial in Worldwide (Part 1, Dose Level 1 and Dose Level 2a: Ipatasertib, Part 1,

Completed
  • Breast Cancer
  • +2 more
  • Part 1, Dose Level 1 and Dose Level 2a: Ipatasertib
  • +3 more
  • San Marcos, California
  • +16 more
Jan 25, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Capecitabine, Eribulin)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan (DS-8201a)
  • +5 more
  • Chandler, Arizona
  • +207 more
Jan 25, 2022